Anticholinergic adjunct therapy for gastric cancers
This technology is a method for treating gastric cancers by inhibiting the cholinergic receptors that could be combined with existing chemotherapies for an improved treatment regimen.
Readily-available and well-tolerated May increase the effectiveness of current standard-of-care therapies Inexpensive and currently FDA-approved anticholinergic drugs will have minimal effects on cost of treatment
Adjuvant treatment for patients with gastric cancer undergoing chemo- and/or radiotherapyPre-symptomatic treatment for patients at high risk of developing gastric cancerNeoadjuvant (pre-surgical) treatment for patients with resectable gastric tumorsAlternative therapy for gastric cancer in place of invasive surgeryResearch tool for examining the molecular biology and cellular pathogenesis of gastric cancerResearch tool for investigating effects of neurotransmitters, innervation, and cholinergic blockade on cancer
None
美國
